| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8453459 | Leukemia Research | 2016 | 9 Pages |
Abstract
The 7on/14off regimen showed a more favorable safety profile; no MTD was established. Efficacy was seen using both regimens providing impetus for further study of HDM2 inhibitors in subjects with AML.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Farhad Ravandi, Ivana Gojo, Mrinal M. Patnaik, Mark D. Minden, Hagop Kantarjian, Amy O. Johnson-Levonas, Craig Fancourt, Raymond Lam, Mary Beth Jones, Clayton D. Knox, Shelonitda Rose, Payal Shah Patel, Raoul Tibes,